(Q54150095)

25 May 2018

reason for preferred rank

title

Silvazine™ (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates (English)

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)00047-8

2 December 2024

Silvazine (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9429028

2 December 2024

1 reference

1 reference

1 reference

N. George

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9429028

2 December 2024

J. Faoagali

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9429028

2 December 2024

M. Muller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9429028

2 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9429028

2 December 2024

publication date

1 September 1997

1 reference

25 May 2018

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9429028

full work available at URL

2 December 2024

https://api.elsevier.com/content/article/PII:S0305417997000478?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)00047-8

https://api.elsevier.com/content/article/PII:S0305417997000478?httpAccept=text/plain

2 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)00047-8

2 December 2024

1 reference

25 May 2018

volume

23

1 reference

25 May 2018

issue

6

1 reference

25 May 2018

page(s)

493-495

1 reference

25 May 2018

Are thermolabile splints a source of nosocomial infection?

cites work

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)50047-8

7 January 2021

Gentamicin- and silver-resistant pseudomonas in a burns unit

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)50047-8

7 January 2021

Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)50047-8

7 January 2021

Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)50047-8

7 January 2021

Escharotomy in burns

series ordinal

2

1 reference

https://api.crossref.org/works/10.1016/S0305-4179(97)00047-8

2 December 2024

Identifiers

1 reference

25 May 2018

1 reference

25 May 2018